FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4245069998> ?p ?o ?g. }

• W4245069998 endingPage "2070" @default.
• W4245069998 startingPage "2070" @default.
• W4245069998 abstract "Abstract Resistance towards apoptotic stimuli mediated by overexpression of antiapoptotic factors or extracellular survival signals like B-cell receptor stimulation (BCR) are considered to be responsible for accumulation of malignant B cells in CLL . TOSO, also known as Fas-inhibitory molecule 3 (FAIM3), was identified as overexpressed candidate gene in CLL based on re-evaluation of publicly available microarray data sets. Based on primary CLL samples from 106 patients, TOSO expression was compared to healthy donor B cells using quantitative real-time PCR, western-blot, flow cytometry and immunohistochemistry. To reveal underlying mechanisms of TOSO overexpression, B-cell receptor (BCR) and CD40Ligand stimulation as well as bone marrow stroma cell co-incubation was performed. Apoptotic resistance was assessed by annexin V/7-AAD flow cytometry in context of CH11-Fas-agonistic antibody. TOSO was identified to exhibit elevated relative expression of 6.8 compared to healthy donor B cells using quantitative real-time PCR (p=0.004). High levels of TOSO expression in CLL correlated with high leukocyte count, advanced Binet stage, previous need for chemotherapy and unmutated IgVH status. CD38+ CLL subsets harboring proliferative activity showed significantly enhanced TOSO expression. Immunohistochemistry revealed upregulation of TOSO in lymph nodes of CLL patients. In lymph nodes derived from healthy donors TOSO was detected in single plasmocytoid cells within the germinal center and in the marginal zone. No specific staining was seen in follicular lymphomas. CLL-specific upregulation of TOSO was confirmed by RT-PCR, samples of follicular lymphomas, DLBCL, marginal zone lymphoma and Hodgkin cell lines did not reveal TOSO up-regulation. We evaluated functional mechanisms of aberrant TOSO expression in CLL cells and identified TOSO expression significantly being induced by BCR-stimulation compared to control cells (relative expression (RE) 8.25 vs. 4.86, p=0.013). In contrast, CD40L signaling significantly reduced TOSO expression (RE 2.60; p=0.007). Spontaneous apoptosis of CLL cells was significantly reduced by BCR-stimulus, in CD40Ligandstimulated CLL samples a slight sensitization towards Fas-mediated apoptosis was seen. In summary, we show that the anti-apoptotic factor TOSO is associated with progressive disease and enhanced in the proliferative CD38+ cell subset. Both association with unmutated IgVH and the specific induction of TOSO via the BCR suggest autoreactive BCR signaling as a key mediator of apoptosis resistance in CLL. Down-regulation of TOSO by CD40Ligand in the context of CD40Ligand-mediated Fas-sensitization of CLL reveal TOSO as a new anti-apoptotic factor in CLL. CLL-specific over-expression of the transmembrane protein might further offer new therapeutic strategies in CLL treatment." @default.
• W4245069998 created "2022-05-12" @default.
• W4245069998 creator A5009769102 @default.
• W4245069998 creator A5018804552 @default.
• W4245069998 creator A5036940707 @default.
• W4245069998 creator A5044687687 @default.
• W4245069998 creator A5049203352 @default.
• W4245069998 creator A5051152518 @default.
• W4245069998 creator A5076077834 @default.
• W4245069998 creator A5077811081 @default.
• W4245069998 creator A5078097779 @default.
• W4245069998 creator A5082067764 @default.
• W4245069998 date "2008-11-16" @default.
• W4245069998 modified "2023-10-11" @default.
• W4245069998 title "Overexpression of TOSO in CLL Is Triggered by B-Cell Receptor Signaling and Associated with Progressive Disease." @default.
• W4245069998 doi "https://doi.org/10.1182/blood.v112.11.2070.2070" @default.
• W4245069998 hasPublicationYear "2008" @default.
• W4245069998 type Work @default.
• W4245069998 citedByCount "0" @default.
• W4245069998 crossrefType "journal-article" @default.
• W4245069998 hasAuthorship W4245069998A5009769102 @default.
• W4245069998 hasAuthorship W4245069998A5018804552 @default.
• W4245069998 hasAuthorship W4245069998A5036940707 @default.
• W4245069998 hasAuthorship W4245069998A5044687687 @default.
• W4245069998 hasAuthorship W4245069998A5049203352 @default.
• W4245069998 hasAuthorship W4245069998A5051152518 @default.
• W4245069998 hasAuthorship W4245069998A5076077834 @default.
• W4245069998 hasAuthorship W4245069998A5077811081 @default.
• W4245069998 hasAuthorship W4245069998A5078097779 @default.
• W4245069998 hasAuthorship W4245069998A5082067764 @default.
• W4245069998 hasConcept C10205521 @default.
• W4245069998 hasConcept C126322002 @default.
• W4245069998 hasConcept C159654299 @default.
• W4245069998 hasConcept C159912055 @default.
• W4245069998 hasConcept C185592680 @default.
• W4245069998 hasConcept C203014093 @default.
• W4245069998 hasConcept C2778453870 @default.
• W4245069998 hasConcept C28328180 @default.
• W4245069998 hasConcept C502942594 @default.
• W4245069998 hasConcept C54355233 @default.
• W4245069998 hasConcept C553184892 @default.
• W4245069998 hasConcept C71924100 @default.
• W4245069998 hasConcept C86803240 @default.
• W4245069998 hasConcept C96926380 @default.
• W4245069998 hasConceptScore W4245069998C10205521 @default.
• W4245069998 hasConceptScore W4245069998C126322002 @default.
• W4245069998 hasConceptScore W4245069998C159654299 @default.
• W4245069998 hasConceptScore W4245069998C159912055 @default.
• W4245069998 hasConceptScore W4245069998C185592680 @default.
• W4245069998 hasConceptScore W4245069998C203014093 @default.
• W4245069998 hasConceptScore W4245069998C2778453870 @default.
• W4245069998 hasConceptScore W4245069998C28328180 @default.
• W4245069998 hasConceptScore W4245069998C502942594 @default.
• W4245069998 hasConceptScore W4245069998C54355233 @default.
• W4245069998 hasConceptScore W4245069998C553184892 @default.
• W4245069998 hasConceptScore W4245069998C71924100 @default.
• W4245069998 hasConceptScore W4245069998C86803240 @default.
• W4245069998 hasConceptScore W4245069998C96926380 @default.
• W4245069998 hasIssue "11" @default.
• W4245069998 hasLocation W42450699981 @default.
• W4245069998 hasOpenAccess W4245069998 @default.
• W4245069998 hasPrimaryLocation W42450699981 @default.
• W4245069998 hasRelatedWork W13281853 @default.
• W4245069998 hasRelatedWork W18131798 @default.
• W4245069998 hasRelatedWork W19370465 @default.
• W4245069998 hasRelatedWork W2040820 @default.
• W4245069998 hasRelatedWork W21125381 @default.
• W4245069998 hasRelatedWork W22111984 @default.
• W4245069998 hasRelatedWork W2999344 @default.
• W4245069998 hasRelatedWork W3190432 @default.
• W4245069998 hasRelatedWork W3242173 @default.
• W4245069998 hasRelatedWork W7987303 @default.
• W4245069998 hasVolume "112" @default.
• W4245069998 isParatext "false" @default.
• W4245069998 isRetracted "false" @default.
• W4245069998 workType "article" @default.